Molecular mechanisms dictating Sirt1/HIF-2 signaling during hypoxia

缺氧期间Sirt1/HIF-2信号传导的分子机制

基本信息

  • 批准号:
    8195371
  • 负责人:
  • 金额:
    $ 30.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-15 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The ability to recognize and respond to environmental stress is an essential characteristic of all living organisms. A low oxygen state, or hypoxia, is an environmental stress encountered under physiological as well as pathophysiological disease states such as myocardial infarction and stroke. In higher eukaryotes, the cell-intrinsic transcriptional hypoxia response includes actions mediated by Hypoxia Inducible Factor (HIF) transcription factors. In vertebrates, the HIF family is comprised of three members with HIF-1 and HIF-2 being essential for survival as indicated by results from genetic ablation studies in mice. Despite their similarity at the protein level, HIF-1 and HIF-2 have distinct biological roles. HIF-2 is the specific HIF factor responsible for induction of erythropoietin and of major antioxidant enzymes (AOE) in adult mice, thereby regulating cell survival and protective cellular responses against oxidative stress, respectively. We recently demonstrated that HIF-2, but not HIF-1, signaling during hypoxia is selectively augmented by Sirtuin 1 (Sirt1), a deacetylase also implicated in aging, nutrient sensing, and genotoxic stress response. Our central hypothesis is that Sirt1/HIF-2 signaling is an essential signaling pathway for protection against hypoxia-induced damage in mammals. Preliminary data within this proposal reveal that Sirt1 levels increase during hypoxia, HIF-2 is acetylated by specific cellular acetyltransferases during hypoxia, and cardiomyocyte-specific HIF-2 ablation in mice results in worse outcome following myocardial infarction. The experiments proposed are aimed at elucidating the mechanism and biological role for Sirt1/HIF-2 signaling in mammals using test tube, cell culture, and animal model studies. Our long-term goals are to identify the prosurvival mechanisms activated during hypoxia and to leverage this knowledge to develop novel therapeutic agents for treatment of myocardial infarction and stroke, the leading causes of morbidity and mortality in US adults today. The Specific Aims of this proposal are as follows: Aim 1: Define the role of HIF signaling in Sirt1 activation during hypoxia Aim 2: Define the role of acetylation in Sirt1/HIF-2 signaling Aim 3: Define the role of HIF-2 in cardiac physiology after myocardial infarction PUBLIC HEALTH RELEVANCE: A low oxygen level is a major feature of several human diseases including heart attack, stroke, and cancer. When faced with this stress, cells in our body respond by turning on genes in an attempt to survive. Understanding how this response is controlled will allow us to design new drugs that will save cells (as desired after a heart attack or stroke) or to kill cells (as desired in the case of cancer).
描述(由申请人提供):识别和应对环境压力的能力是所有生物的基本特征。低氧状态,或低氧,是一种在生理和病理生理疾病状态下遇到的环境应激,如心肌梗死和中风。在高等真核生物中,细胞固有的转录低氧反应包括由低氧诱导因子(HIF)转录因子介导的作用。在脊椎动物中,HIF家族由三个成员组成,小鼠的遗传消融研究结果表明,HIF-1和HIF-2是生存所必需的。尽管HIF-1和HIF-2在蛋白质水平上相似,但它们具有不同的生物学作用。HIF-2是诱导成年小鼠促红细胞生成素和主要抗氧化酶(AOE)的特异性HIF因子,从而分别调节细胞存活和保护细胞对氧化应激的反应。我们最近证明,Sirtuin 1(Sirt1)选择性地增强了缺氧过程中的HIF-2信号,而不是HIF-1信号。Sirt1是一种脱乙酰酶,也与衰老、营养感知和遗传毒性应激反应有关。我们的中心假设是Sirt1/HIF-2信号通路是保护哺乳动物免受缺氧损伤的重要信号通路。该方案的初步数据显示,Sirt1水平在低氧期间增加,HIF-2在低氧期间被特定的细胞乙酰转移酶乙酰化,而小鼠心肌细胞特异性HIF-2的消融会导致心肌梗死后更糟糕的预后。这些实验旨在通过试管、细胞培养和动物模型研究来阐明Sirt1/HIF-2信号在哺乳动物中的机制和生物学作用。我们的长期目标是确定在低氧期间激活的生存机制,并利用这一知识开发用于治疗心肌梗死和中风的新型治疗剂,这两种疾病是当今美国成年人发病率和死亡率的主要原因。该方案的具体目的如下:目标1:确定缺氧时Sirt1激活中HIF信号的作用目标2:确定乙酰化在Sirt1/HIF-2信号中的作用目标3:确定HIF-2在心肌梗死后心脏生理中的作用 与公共卫生相关:低氧水平是包括心脏病发作、中风和癌症在内的几种人类疾病的主要特征。当面对这种压力时,我们体内的细胞会通过启动基因来做出反应,试图生存下来。了解这种反应是如何控制的,将使我们能够设计新的药物来拯救细胞(如心脏病发作或中风后所需)或杀死细胞(如癌症所需)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Anthony Garcia其他文献

Joseph Anthony Garcia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Anthony Garcia', 18)}}的其他基金

ShEEP Request for A Namocell PALA Single CellDispenser
ShEEP 请求 Namocell PALA 单细胞分配器
  • 批准号:
    10739131
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanistic studies and translational applications of stress signaling in anemia
贫血中应激信号传导的机制研究和转化应用
  • 批准号:
    9913371
  • 财政年份:
    2019
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanistic Studies and Translational Applications of Stress Signaling in Anemia
贫血中应激信号传导的机制研究和转化应用
  • 批准号:
    9177621
  • 财政年份:
    2016
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular mechanisms dictating Sirt1/HIF-2 signaling during hypoxia
缺氧期间Sirt1/HIF-2信号传导的分子机制
  • 批准号:
    8301593
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular mechanisms dictating Sirt1/HIF-2 signaling during hypoxia
缺氧期间Sirt1/HIF-2信号传导的分子机制
  • 批准号:
    8471768
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular mechanisms dictating Sirt1/HIF-2 signaling during hypoxia
缺氧期间Sirt1/HIF-2信号传导的分子机制
  • 批准号:
    8668131
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Dynamic Regulation of Erythropoietin Gene Expression in Mammals.
哺乳动物促红细胞生成素基因表达的动态调节。
  • 批准号:
    10589528
  • 财政年份:
    2009
  • 资助金额:
    $ 30.2万
  • 项目类别:
Dynamic Regulation of Erythropoietin Gene Expression in Mammals
哺乳动物促红细胞生成素基因表达的动态调控
  • 批准号:
    7691086
  • 财政年份:
    2009
  • 资助金额:
    $ 30.2万
  • 项目类别:
Dynamic Regulation of Erythropoietin Gene Expression in Mammals
哺乳动物促红细胞生成素基因表达的动态调控
  • 批准号:
    8963422
  • 财政年份:
    2009
  • 资助金额:
    $ 30.2万
  • 项目类别:
Dynamic Regulation of Erythropoietin Gene Expression in Mammals
哺乳动物促红细胞生成素基因表达的动态调控
  • 批准号:
    8442054
  • 财政年份:
    2009
  • 资助金额:
    $ 30.2万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了